prednisone + sodium liothyronine

This is a combination drug consisting of prednisone, a synthetic glucocorticoid corticosteroid, and sodium liothyronine (liothyronine sodium), a synthetic form of the thyroid hormone triiodothyronine (T3). Prednisone acts primarily as an anti-inflammatory and immunosuppressive agent by binding to the glucocorticoid receptor, modulating gene expression, and suppressing immune responses. Sodium liothyronine replaces or supplements endogenous T3 in patients with hypothyroidism or other conditions requiring increased thyroid hormone activity. The combination may be used in clinical scenarios where both anti-inflammatory/immunosuppressive effects and rapid thyroid hormone replacement are needed—such as myxedema coma or certain diagnostic procedures—though this specific fixed-dose combination is not widely marketed under a unique brand name. Both drugs have distinct mechanisms but can interact pharmacologically; for example, corticosteroids like prednisone can decrease levels of thyroxine-binding globulin, affecting circulating thyroid hormones[1][5][9].